BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 15871083)

  • 1. [TACE: therapy of the HCC before liver transplantation--experiences].
    Herber S; Schneider J; Brecher B; Höhler T; Thelen M; Otto G; Pitton MB
    Rofo; 2005 May; 177(5):681-90. PubMed ID: 15871083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of multislice CT and histomorphology in HCC following TACE: predictors of outcome.
    Herber S; Biesterfeld S; Franz U; Schneider J; Thies J; Schuchmann M; Düber C; Pitton MB; Otto G
    Cardiovasc Intervent Radiol; 2008; 31(4):768-77. PubMed ID: 18196335
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Transarterial chemoembolization (TACE) of the hepatocellular carcinoma (HCC) in patients with portal vein thrombosis--experiences].
    Herber S; Pitton M; Mönch C; Schneider J; Manzl N; Kummer I; Kanzler S; Schuchmann M; Junginger T; Düber C; Otto G
    Zentralbl Chir; 2007 Aug; 132(4):306-15. PubMed ID: 17724633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Single center experience over a 5-year period with sequential transarterial chemoembolization (TACE) in the treatment of hepatocellular carcinoma (HCC)].
    Herber SC; Otto G; Woerns M; Moench C; Kanzler S; Junginger T; Schneider J; Schuchmann M; Kummer I; Manzl N; Düber C; Pitton MB
    Rofo; 2007 Mar; 179(3):289-99. PubMed ID: 17325996
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantation.
    Chapman WC; Majella Doyle MB; Stuart JE; Vachharajani N; Crippin JS; Anderson CD; Lowell JA; Shenoy S; Darcy MD; Brown DB
    Ann Surg; 2008 Oct; 248(4):617-25. PubMed ID: 18936575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transarterial chemoembolization for hepatocellular carcinoma: volumetric and morphologic CT criteria for assessment of prognosis and therapeutic success-results from a liver transplantation center.
    Vogl TJ; Trapp M; Schroeder H; Mack M; Schuster A; Schmitt J; Neuhaus P; Felix R
    Radiology; 2000 Feb; 214(2):349-57. PubMed ID: 10671580
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatocellular carcinoma: CT for tumor response after transarterial chemoembolization in patients exceeding Milan criteria--selection parameter for liver transplantation.
    Bargellini I; Vignali C; Cioni R; Petruzzi P; Cicorelli A; Campani D; De Simone P; Filipponi F; Bartolozzi C
    Radiology; 2010 Apr; 255(1):289-300. PubMed ID: 20308465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis.
    Majno PE; Adam R; Bismuth H; Castaing D; Ariche A; Krissat J; Perrin H; Azoulay D
    Ann Surg; 1997 Dec; 226(6):688-701; discussion 701-3. PubMed ID: 9409568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Disease course after liver transplantation for hepatocellular carcinoma in patients with complete tumor necrosis in liver explants after performance of bridging treatments.
    Sotiropoulos GC; Malago M; Molmenti EP; Radtke A; Brokalaki EI; Nadalin S; Lang H; Frilling A; Baba HA; Kühl H; Verhagen R; Broelsch CE
    Eur J Med Res; 2005 Dec; 10(12):539-42. PubMed ID: 16356871
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transarterial Chemoembolization Prior to Liver Transplantation in Patients with Hepatocellular Carcinoma.
    Hołówko W; Wróblewski T; Wojtaszek M; Grąt M; Kobryń K; Ziarkiewicz-Wróblewska B; Krawczyk M
    Ann Transplant; 2015 Dec; 20():764-8. PubMed ID: 26712800
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term outcomes of hepatocellular carcinoma that underwent chemoembolization for bridging or downstaging.
    Affonso BB; Galastri FL; da Motta Leal Filho JM; Nasser F; Falsarella PM; Cavalcante RN; de Almeida MD; Felga GEG; Valle LGM; Wolosker N
    World J Gastroenterol; 2019 Oct; 25(37):5687-5701. PubMed ID: 31602168
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nonresectable combined hepatocellular carcinoma and cholangiocarcinoma: analysis of the response and prognostic factors after transcatheter arterial chemoembolization.
    Kim JH; Yoon HK; Ko GY; Gwon DI; Jang CS; Song HY; Shin JH; Sung KB
    Radiology; 2010 Apr; 255(1):270-7. PubMed ID: 20308463
    [TBL] [Abstract][Full Text] [Related]  

  • 13. How to decide about liver transplantation in patients with hepatocellular carcinoma: size and number of lesions or response to TACE?
    Otto G; Schuchmann M; Hoppe-Lotichius M; Heise M; Weinmann A; Hansen T; Pitton MP
    J Hepatol; 2013 Aug; 59(2):279-84. PubMed ID: 23587474
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to transarterial chemoembolization as a biological selection criterion for liver transplantation in hepatocellular carcinoma.
    Otto G; Herber S; Heise M; Lohse AW; Mönch C; Bittinger F; Hoppe-Lotichius M; Schuchmann M; Victor A; Pitton M
    Liver Transpl; 2006 Aug; 12(8):1260-7. PubMed ID: 16826556
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients.
    Takayasu K; Arii S; Ikai I; Omata M; Okita K; Ichida T; Matsuyama Y; Nakanuma Y; Kojiro M; Makuuchi M; Yamaoka Y;
    Gastroenterology; 2006 Aug; 131(2):461-9. PubMed ID: 16890600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Viable hepatocellular carcinoma around retained iodized oil after transarterial chemoembolization: radiofrequency ablation of viable tumor plus retained iodized oil versus viable tumor alone.
    Kim JH; Kim PN; Won HJ; Shin YM
    AJR Am J Roentgenol; 2014 Nov; 203(5):1127-31. PubMed ID: 25341154
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Milan criteria are useful predictors for favorable outcomes in hepatocellular carcinoma patients undergoing liver transplantation after transarterial chemoembolization.
    Kim DY; Choi MS; Lee JH; Koh KC; Paik SW; Yoo BC; Shin SW; Choo SW; Do YS; Rhee JC
    World J Gastroenterol; 2006 Nov; 12(43):6992-7. PubMed ID: 17109521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Survival of 184 patients with hepatocellular carcinoma in cirrhotic liver treated with chemoembolization. A multicenter study].
    Gattoni F; Cornalba G; Brambilla G; Dova S; Pompili G; Rampoldi A; Damiani G; Carnevali G; Uslenghi CM
    Radiol Med; 1998 Apr; 95(4):362-8. PubMed ID: 9676217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Optimal methods for measuring eligibility for liver transplant in hepatocellular carcinoma patients undergoing transarterial chemoembolization.
    Kim HD; Shim JH; Kim GA; Shin YM; Yu E; Lee SG; Lee D; Kim KM; Lim YS; Lee HC; Chung YH; Lee YS
    J Hepatol; 2015 May; 62(5):1076-84. PubMed ID: 25529626
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Liver transplantation versus supraselective transarterial chemoembolization in palliative patients with hepatocellular carcinoma exceeding the Milan Criteria - is it time for a more individual approach?
    Heinzow HS; Brockmann JG; Köhler M; Wolters HH; Senninger N; Schmidt H; Meister T
    Ann Transplant; 2013 Oct; 18():515-24. PubMed ID: 24081430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.